Diagnostic performance of qualitative and quantitative shear wave elastography in differentiating malignant from benign breast masses, and association with the histological prognostic factors

Abstract

Background: To determine the diagnostic performance of qualitative and quantitative shear wave elastography (SWE) and the optimal cutoff values of the quantitative SWE parameters in differentiating malignant from benign breast masses, and to evaluate the association between the quantitative SWE parameters and histological prognostic factors. Methods: A gray scale ultrasound and SWE were prospectively performed on a total of 244 breast masses (148 benign, and 96 malignant) in 228 consecutive patients before an ultrasound-guided needle biopsy. The qualitative SWE and quantitative SWE parameters (the mean elasticity, maximum elasticity, and elasticity ratio) were measured in each mass. The diagnostic performance of SWE and the optimal cutoff values of the quantitative SWE parameters were obtained. An association analysis of the parameters and histological prognostic factors was performed. Results: The malignant masses had a more heterogeneous pattern on the qualitative SWE than benign masses (P<0.001). The quantitative SWE parameters of the malignant masses were higher than those of the benign masses (P<0.001); the mean elasticity, maximum elasticity, and elasticity ratio of the benign masses were 19.73 kPa, 23.98 kPa, and 2.78, respectively; and the mean elasticity, maximum elasticity, and elasticity ratio of the malignant masses were 88.13 kPa, 98.48 kPa, and 10.64, respectively. The optimal cutoff value of the mean elasticity was 30 kPa, of the maximum elasticity was 36 kPa, and of the elasticity ratio was 4.5. The maximum elasticity had the highest AUC. Combining the three SWE parameters to differentiate between the malignant and benign masses increased the negative predictive value (NPV), which correctly downgraded 72.73% of BI-RADS category 4A masses to BI-RADS category 3. No statistically significant association was found between the quantitative SWE parameters and the tumor grading, tumor types, axillary lymph node statuses, or molecular subtypes of the breast cancers (P>0.05). Conclusions: The qualitative and quantitative SWE provided good diagnostic performance in differentiating malignant and benign masses. The maximum elasticity of the quantitative SWE parameters had the best diagnostic performance. Adding the three combined quantitative SWE parameters to the BI-RADS category 4A masses potentially downgraded them to BI-RADS category 3 and avoided unnecessary biopsies. No statistically significant association was found between the quantitative SWE parameters and the histological prognostic factors.

TGF-β1 and Its Signal Transduction Pathways: Are They Corelated With The Elastic Characteristics of Breast Lesions?

“…SWE could quantitatively evaluate the elastic characteristics of breast lesions and more accurately judge the benign and malignant breast lesions. Our study showed that there were signi cant differences in elastic characteristics between benign and malignant breast lesions, which were the same as those of previous studies [8,20]. For malignant breast lesions, a large number of cancer cells proliferated, invaded and in ltrated the normal breast stroma and adipose tissue, and interacted with the tumor microenvironment, causing complex connective tissue hyperplasia and brosis, which were important typical pathological changes in the process of tumor development and invasion, they could lead to overexpression and accumulation of ECM components, rearrangement and cross-linking of ECM structure [21,22], and increase the stiffness of the lesions.…”

“…Shear wave elastography (SWE) is a new ultrasound technology based on conventional ultrasound, which quanti es the tissue stiffness information with speci c numerical values [7]. And its value in differential diagnosis of benign and malignant breast lesions has been proved by many studies [7][8][9].…”

Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer

“…Magnetic resonance imaging (MRI), ultrasonography, and mammography are key modalities for breast tumor diagnosis and the subsequent choice of appropriate therapy (5). MRI is highly sensitive to the detection of breast cancer and is the most sensitive technique for screening highrisk women and detecting contralateral or multifocal disease (6)(7)(8).…”

The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer

“…Breast magnetic resonance imaging (MRI) is a more sensitive modality to detect benign and malignant breast lesions compared with mammography and ultrasound, especially in young patients with a dense mammary gland (13,14). In patients undergoing NAC, breast MRI is also an efficient noninvasive method in evaluating the efficacy of chemotherapy (15).…”